| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.091 | 0.002 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.004 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |